[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 16 sources · 28 days · First seen · Last updated

Evotec leadership restructuring

Overview

Evotec has undergone a series of leadership transitions following a period of significant corporate growth. Initially, the company announced a management restructuring that included the promotion of two internal candidates to new executive roles.

By late September, the company confirmed that Chief Scientific Officer Dr. Cord Dohrmann will step down on September 30, 2026. The departure was described as being by “mutual agreement.” Dr. Dohrmann, who joined the company in 2010, was noted for his role in developing iPSC-based technologies and Omics capacities. Evotec is currently searching for a successor.

As of late September 2026, Evotec’s stock has shown signs of stability despite the upcoming departure of Dr. Dohrmann after 16 years with the firm.

Entities

Technical University of Denmark · Evotec SE · Nasdaq · Inventiva S.A. · Jogeir Romestrand

Timeline

  1. [BUSINESS] 10 sources
    CTS Eventim shares fluctuate following sudden CFO departure

    CTS Eventim shares faced volatility following the sudden departure of CFO William Willms, while Evotec announced the exit of its Chief Scientific Officer after 16 years.

  2. [BUSINESS] 6 sources
    Evotec announces leadership changes following record year

    Evotec has announced leadership changes and promoted two internal employees to new executive roles following a record-breaking year of growth.

Sources

4investors.de · ad-hoc-news.de · assignmenthelp.net.au · biopharmatrend.com · boersennews.de · bygdebladet.com · finanzen.at · finanzen.net · ing.dk · it-boltwise.de · komputer.no · nett.no · news.alphastreet.com · pctidningen.se · sharedeals.de · stocknews.com

This summary has been updated 1 time: see revision history